跳到正文
原文
Endpoints News 生物医药· Max Gelman·· 18 天前AI 评分30

FDA 对 Bright Minds 试验抗癫痫药物部分暂停临床试验

FDA puts Bright Minds drug on partial hold, stock tanks

AI 导读

FDA 对 Bright Minds 生物科学公司的一款试验抗癫痫药物实施部分临床暂停,具体原因未详述。

正文

The FDA placed an ex­per­i­men­tal seizure drug from Bright Minds Bio­sciences on a par­tial clin­i­cal hold, the com­pa­ny an­nounced Mon­day.

Reg­u­la­tors is­sued the hold for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news